Skip to main content

Month: July 2020

Verizon Communications to report earnings July 24, 2020

BASKING RIDGE, N.J., July 23, 2020 (GLOBE NEWSWIRE) — Verizon Communications Inc. (NYSE, Nasdaq: VZ) will report second quarter 2020 earnings on Friday, July 24.The company will present results on a webcast beginning at 8:30 a.m. Eastern Time. Access instructions and presentation materials, including Verizon’s earnings news release and financial tables, will be available at 7:30 a.m. on Verizon’s Investor Relations website, https://www.verizon.com/about/investors.Verizon Communications Inc. (NYSE, Nasdaq: VZ) was formed on June 30, 2000 and is celebrating its 20th year as one of the world’s leading providers of technology, communications, information and entertainment products and services. Headquartered in New York City and with a presence around the world, Verizon generated revenues of $131.9 billion in 2019. The company offers...

Continue reading

Verrica Pharmaceuticals Announces Clinical and Drug Development Leadership Changes

– Dr. Gary Goldenberg appointed Chief Medical Officer; Dr. Brad Catalone assumes the role of Head of Drug Development –– New leadership strengthens expertise in Clinical, Chemistry, Manufacturing, and Controls (CMC), and Regulatory Affairs –WEST CHESTER, Pa., July 23, 2020 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for viral skin diseases requiring medical interventions, today announced key appointments to its drug development team.Current Board of Directors (the “Board”) member Dr. Gary Goldenberg, a renowned thought leader in the field of dermatology, is stepping down to become Verrica’s Chief Medical Officer, effective August 1, 2020. Verrica announced separately today that Dr. Lawrence Eichenfield is joining the Board on August 1, 2020,...

Continue reading

Iovance Biotherapeutics to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Thursday, August 6, 2020

SAN CARLOS, Calif., July 23, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, will report its second quarter 2020 financial results on Thursday, August 6, 2020. Management will host a conference call and live audio webcast to discuss these results and provide a corporate update at 4:30 p.m. EDT.To participate in the conference call, please dial 1-844-646-4465 (domestic) or 1-615-247-0257 (international) and reference the access code 7875997. The live webcast can be accessed in the Investors section of the Company’s website at www.iovance.com. The archived webcast will be available for one year.About Iovance Biotherapeutics, Inc.Forward-Looking StatementsCertain matters discussed in this press release are “forward-looking...

Continue reading

Amerigo Reports Q2-2020 Production Results and Provides Operational Update

VANCOUVER, British Columbia, July 23, 2020 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (“Amerigo” or the “Company”) (TSX: ARG) announced today Q2-2020 production results from Minera Valle Central (“MVC”), the Company’s 100% owned operation located near Rancagua, Chile.MVC produced 12.97 million pounds (“M lbs”) of copper at a cash cost of US$1.72/lb per pound, and 0.35 M lbs of molybdenum. In Q2-2020, MVC’s copper production from fresh and Cauquenes tailings increased 20% compared to Q1-2020.Copper production results are in line with the Company’s 2020 guidance (refer to our news release of February 19, 2020) where the Company announced a reduction in Cauquenes tonnage processing to approximately 40,000 tonnes per day (“TPD”) through H1-2020 in response to drought conditions then present in central...

Continue reading

American National Bankshares Reports Second Quarter Earnings

DANVILLE, Va., July 23, 2020 (GLOBE NEWSWIRE) — American National Bankshares Inc. (NASDAQ: AMNB) (“American National” or the “Company”) today reported second quarter 2020 earnings of $5.5 million, or $0.50 per diluted common share. Those results compare to a net loss of $1.2 million, or ($0.11) per diluted common share, during the same quarter in the prior year, and net income of $8.5 million, or $0.77 per diluted common share, recognized for the first quarter of 2020. Earnings for the first six months of 2020 were $14.0 million, or $1.28 per diluted common share, compared to $4.8 million, or $0.48 per diluted common share for the same period of 2019. Earnings for the second quarter and six months of 2019 were impacted by $10.9 million and $11.3 million, respectively, in merger related expenses.President and Chief Executive Officer...

Continue reading

FirstService Reports Solid Second Quarter Operating Results

Growth Tempered By COVID-19 PandemicOperating highlights:TORONTO, July 23, 2020 (GLOBE NEWSWIRE) — FirstService Corporation (TSX: FSV; NASDAQ: FSV) today reported results for its second quarter ended June 30, 2020. All amounts are in US dollars.Revenues for the second quarter were $621.6 million, an 8% increase relative to the same quarter in the prior year, Adjusted EBITDA (note 1) increased 10% to $71.2 million, and Adjusted EPS (note 2) was $0.86, versus $1.12 in the prior year quarter. During the second quarter, FirstService reported GAAP Operating Earnings of $44.9 million, versus an operating loss of $268.5 million in the prior year period, reflecting the 2019 settlement of the long-term incentive arrangement (“LTIA”) with its Founder and Chairman in the amount of $314.4 million. The GAAP earnings per share was $0.64 in the...

Continue reading

ACNB Corporation Announces Third Quarter Cash Dividend

GETTYSBURG, Pa., July 23, 2020 (GLOBE NEWSWIRE) — The Board of Directors of ACNB Corporation recently approved and declared the payment of the regular quarterly cash dividend. The cash dividend of $0.25 per share is payable on September 15, 2020, to shareholders of record on August 31, 2020. This per share amount will result in aggregate dividend payments of approximately $2.2 million to ACNB Corporation shareholders in the third quarter of 2020. Compared to a year ago, ACNB Corporation also paid a $0.25 dividend per share in the third quarter of 2019. “Amidst the unprecedented and ongoing challenges of the COVID-19 pandemic in 2020, the Board of Directors voted to provide ACNB Corporation shareholders with a stable quarterly cash dividend of $0.25 per share, which is the same amount paid for the past five quarters beginning in...

Continue reading

NeuroMetrix Reports Q2 2020 Financial Results

WOBURN, Mass., July 23, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2020. The Company is a leading developer of neurostimulation-based medical devices that are used to diagnose and treat chronic health conditions.Q2 2020 Highlights:Total revenue of $1.4 million provided a gross margin of $0.9 million, at a gross margin rate of 63.6%. The COVID-19 effects on the economy and health care delivery adversely affected customer orders in all product lines. DPNCheck® contributed $0.8 million revenue with about 46% coming from Asian markets. Quell® contributed $0.4 million revenue and ADVANCE $0.1 million revenue.   Operating expenses were reduced to $1.7 million with lower variable spending in S&M and G&A. The R&D program maintained...

Continue reading

Pool Corporation Reports Record Second Quarter Results

HighlightsRecord net sales for Q2 2020 with both overall and base business sales growth of 14%Q2 2020 diluted EPS increase of 20% to a record $3.87 or an increase of 23% to $3.72, excluding tax benefits in both periodsRecord cash provided by operations of $221.2 million, an increase of $123.8 million from the first half of 20192020 earnings guidance increased to $6.90 – $7.30 per diluted share or $7.05 – $7.45, excluding non-cash impairments recorded in Q1 2020, from previous $5.30 – $5.90 range or $5.45 – $6.05, excluding impairmentsCOVINGTON, La., July 23, 2020 (GLOBE NEWSWIRE) — Pool Corporation (Nasdaq/GSM:POOL) today reported record results for the second quarter of 2020.“The second quarter of 2020 presented a unique opportunity for our business as families continued to search for safe, at-home leisure...

Continue reading

Sandy Spring Bancorp Reports Second Quarter Results

OLNEY, Md., July 23, 2020 (GLOBE NEWSWIRE) — Sandy Spring Bancorp, Inc., (Nasdaq-SASR), the parent company of Sandy Spring Bank, today reported a $14.3 million net loss ($0.31 per share) for the second quarter of 2020.  The loss was the result of the combination of merger and acquisition expense, the impact of the current economic forecast in the determination of the allowance for credit losses and the additional provision for credit losses associated with the acquisition of Revere Bank (“Revere”), which closed on April 1, 2020.   The 2020 second quarter’s result compares to net income of $28.3 million ($0.79 per diluted share) for the second quarter of 2019 and $10.0 million ($0.28 per diluted share) for the first quarter of 2020. Operating earnings for the current quarter, which exclude the impact of merger and acquisition expense,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.